In addition, -1Ala-TIMP-3 and T2G-TIMP-3 were able to inhibit the aggrecanases (ADAMTS-4 and -5) and block aggrecan degradation, which is, together with TNF release, a key feature of arthritis [209]. This evidence concerns the gene TNF and arthritic joint disease.